Olon Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is FENOFIBRATE, with a corresponding US DMF Number 15438.
Remarkably, this DMF maintains an Active status since its submission on May 08, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 27, 2016, and payment made on May 13, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II